This didn’t make any headlines.
The city of Itajai, Brazil offered Ivermectin to its citizens during the COVID pandemic. The results were spectacular. Hospitalizations and deaths were cut in half.
Photo by Soumyabrata NURPHOTO VIA GETTY IMAGES
Zero Hedge reported:
Advertisement - story continues below
Early on in the pandemic, before the vaccines were available, the Southern Brazilian city of Itajai offered Ivermectin as a prophylaxis against the disease.
Between July and December of 2020, roughly 220,000 people were offered a dose of 0.2mg/kg/day (roughly 18mg for a 200lb person) as an optional treatment for 2 days, once every two weeks.
133,051 people took them up on it, while 87,466 did not.
After analyzing the data, a team of researchers spanning several Brazilian institutes, the University of Toronto, and Columbia’s EAFIT concluded in a December pre-print study that hospitalization and mortality rates were cut in half over the seven-month period among the Ivermectin group.
Advertisement - story continues below
This is even more impressive when you learn the IVM users were older on average, with 30% >50 yo versus 20% for non-IVM users. The mortality reduction is even higher looking at different age groups. 85% for 31-49 yo and 59% for >50 yo. pic.twitter.com/K6D5naybCS
— Simon Vallée (@sival84) December 11, 2021
The Gateway Pundit is moving back to Disqus! All of your account information and comment history has been saved and will be uploaded as quickly as possible to Disqus. If you do not already have a Disqus account, you will need to create one. Please use the same email address that you used for Insticator for your comment history to be carried over. We greatly appreciate your patience and continued support!